FDA Warning Letter — Qingdao Jiulong Biopharmaceutical Co. Ltd.

Case 56042 — FEI 3006745882

The FDA took a Warning Letter action against Qingdao Jiulong Biopharmaceutical Co. Ltd. on April 14, 2009 (Qingdao, China). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.

Action Details

Facility
Qingdao Jiulong Biopharmaceutical Co. Ltd.
Date
April 14, 2009
Fiscal Year
2009
Product Type
Drugs
Center
CDER
Location
Qingdao (China)